ISRIB (an acronym for Integrated Stress Response inhibitor) is an experimental drug which reverses the effects of eIF2α phosphorylation with an IC50 of 5nM. It was discovered by a group at the University of California through a semi-automated screening of a large library of small molecules.
This page contains content from the copyrighted Wikipedia article "ISRIB"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
